Cargando…
UroVysion(TM) Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives
SIMPLE SUMMARY: Positive UroVysion(TM) fluorescence in situ hybridization (U-FISH) is generally considered urothelial carcinoma (UC). However, in our clinical practice, we found that U-FISH also showed positive findings in non-urothelial carcinomas or even metastatic carcinomas. A review is needed t...
Autores principales: | Ke, Chunjin, Hu, Zhiquan, Yang, Chunguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657137/ https://www.ncbi.nlm.nih.gov/pubmed/36358841 http://dx.doi.org/10.3390/cancers14215423 |
Ejemplares similares
-
Evaluation of UroVysion for Urachal Carcinoma Detection
por: Hu, Zhiquan, et al.
Publicado: (2020) -
UroVysion(™) fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
por: Ke, Chunjin, et al.
Publicado: (2023) -
UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives
por: Nagai, Takashi, et al.
Publicado: (2021) -
UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study
por: Dodurga, Yavuz, et al.
Publicado: (2013) -
Can Reflex UroVysion fluorescence in situ hybridization predict tumor recurrence during follow-up?
por: Kurien, Annamma, et al.
Publicado: (2007)